Senhwa Biosciences, Inc. (TPEX: 6492)
Taiwan
· Delayed Price · Currency is TWD 46.90
-1.30 (-2.70%)
Sep 10, 2024, 1:30 PM CST
Senhwa Biosciences Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -291.54 | -296.31 | -349.63 | -329.26 | -354.88 | -391.43 | Upgrade
|
| Depreciation & Amortization | 11.65 | 10.73 | 7.11 | 6.23 | 7.11 | 8.16 | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.5 | - | - | - | - | - | Upgrade
|
| Stock-Based Compensation | - | -0.64 | 1.03 | 3.47 | 51.45 | 12.83 | Upgrade
|
| Other Operating Activities | -1.03 | -1.11 | -0.25 | -7.91 | 0.22 | 1.79 | Upgrade
|
| Change in Accounts Receivable | - | - | 0.19 | -0.19 | 0.03 | 0.1 | Upgrade
|
| Change in Accounts Payable | 4.86 | 9.74 | -52.3 | 27.19 | 26.23 | -12.55 | Upgrade
|
| Change in Other Net Operating Assets | -3.55 | -8.77 | -6.12 | 0.41 | -2.84 | -3.73 | Upgrade
|
| Operating Cash Flow | -280.1 | -286.35 | -399.97 | -300.05 | -272.68 | -384.83 | Upgrade
|
| Capital Expenditures | -1.95 | -4.61 | -0.37 | -0.24 | -0.39 | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | -0.17 | - | -0.16 | - | - | Upgrade
|
| Other Investing Activities | -0.02 | -0.48 | -0.22 | 0.55 | 0.01 | 0 | Upgrade
|
| Investing Cash Flow | -1.48 | -5.26 | -0.59 | 0.15 | -0.38 | 0 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 9.63 | - | Upgrade
|
| Long-Term Debt Repaid | - | -8.83 | -6.31 | -4.93 | -5.6 | -5.52 | Upgrade
|
| Net Debt Issued (Repaid) | -8.53 | -8.83 | -6.31 | -4.93 | 4.03 | -5.52 | Upgrade
|
| Issuance of Common Stock | - | - | - | 6.81 | 1,807 | 0.28 | Upgrade
|
| Repurchase of Common Stock | - | - | -13.24 | -36.12 | -1.99 | - | Upgrade
|
| Financing Cash Flow | -8.53 | -8.83 | -19.55 | -34.24 | 1,809 | -5.24 | Upgrade
|
| Foreign Exchange Rate Adjustments | 2.08 | 0.11 | 6.67 | -1.85 | -4.29 | -2.15 | Upgrade
|
| Net Cash Flow | -288.03 | -300.33 | -413.44 | -336 | 1,531 | -392.22 | Upgrade
|
| Free Cash Flow | -282.06 | -290.96 | -400.34 | -300.29 | -273.07 | -384.83 | Upgrade
|
| Free Cash Flow Margin | -28205.70% | -29095.90% | -40034.00% | -54597.64% | -44257.86% | -128275.67% | Upgrade
|
| Free Cash Flow Per Share | -3.16 | -3.26 | -4.49 | -3.35 | -3.46 | -5.17 | Upgrade
|
| Cash Interest Paid | 0.58 | 0.54 | 0.54 | 0.53 | 0.19 | 0.34 | Upgrade
|
| Cash Income Tax Paid | 1.45 | 1.91 | 1.36 | -1.32 | 0.41 | 0.31 | Upgrade
|
| Levered Free Cash Flow | -180.9 | -187.1 | -273.62 | -177.76 | -142.89 | -239.77 | Upgrade
|
| Unlevered Free Cash Flow | -180.54 | -186.76 | -273.28 | -177.43 | -142.73 | -239.55 | Upgrade
|
| Change in Net Working Capital | -0.83 | -2.37 | 58.48 | -29.71 | -23.63 | 14.42 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.